Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novexel

2004 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$350M LATEST DEAL AMOUNT
Description

Provider of novel antibiotics to treat bacterial and fungal infections. The company develops antibacterial and anti-fungal agents to overcome the problem of microbial resistance. The company focuses on biology, pharmacology, microbiology and clinical development.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Acquirer
Primary Office
  • Parc Biocitech
  • 102, avenue Gaston Roussel
  • 93230 Romainville
  • France

+33 01 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novexel’s full profile, request a free trial.

Novexel Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Jan-2010 $350M 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 10-Jan-2007 0000 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Dec-2004 $53.6M $53.6M Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Novexel Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
123 Investment Managers Asset Manager Minority 000 0000 000000 0
3i Group PE/Buyout Minority 000 0000 000000 0
Abingworth Management Venture Capital Minority 000 0000 000000 0
Andera Partners PE/Buyout Minority 000 0000 000000 0
Atlas Venture Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Novexel Board Members (11)

Name Representing Role Since Contact
Info
George Horner III Self Board Member 000 0000
Göran Ando Self Board Member 000 0000
Michele Garufi Self Non Executive Director 000 0000
Olivier Litzka Self Board Member 000 0000

7 Former Board Members

You’re viewing 4 of 11 board members. Get the full list »